EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Pharmacological Inhibition of Tropomyosin Receptor Kinase B Reverses Remifentanil-Induced Postoperative Hyperalgesia and Synaptic Remodeling

Lijun Yang, Yu Huang, Bo Long iD

Journal of Pain Research · 2026-06 · Volume 19 · 1-11

DOI: 10.2147/jpr.s598801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pain Research, 2026-06. Verfasst von Lijun Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology,Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fuji…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study investigated the contributions of tropomyosin receptor kinase B (TrkB) signaling to behavioral hyperalgesia and associated spinal synaptic and dendritic remodeling in the rat remifentanil-induced hyperalgesia (RIH) model.

Methods

Forty rats were randomly assigned to four treatment groups (n = 10/group): normal saline + TrkB inhibitor (NS + ANA), surgical incision of the hind paw (I), remifentanil + incision (IR), and remifentanil + incision + TrkB inhibitor (IR + ANA). Paw mechanical withdrawal threshold (PMWT), expression levels of Brain-derived neurotrophic factor (BDNF), TrkB, and synaptic proteins, and dendritic morphology were compared among groups.

Results

Rats in the IR group exhibited significantly reduced mechanical pain thresholds and elevated expression levels of BDNF, TrkB, the glutamate receptor 1 subunit (GluR1), postsynaptic density protein 95 (PSD-95), and synapsin compared to the I group at 48 h post-surgery. In addition, IR rats had longer spinal dendrites with greater branching complexity. Administration of a TrkB inhibitor (IR + ANA group) reversed all these changes, with the exception of upregulated BDNF expression.

Conclusion

This study provides molecular and morphological evidence that TrkB inhibition reverses synaptic structural remodeling in RIH, suggesting TrkB as a potential therapeutic target. The feasibility of TrkB inhibitors for human postoperative hyperalgesia warrants further investigation.

Schlagwörter

Stichwörter der Autor:innen

brain-derived neurotrophic factorhyperalgesianeuroplasticityremifentaniltropomyosin receptor kinase B

Autor:innen und Institutionen

  • Department of Anesthesiology,Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, People's Republic of China.
  • Department of Anesthesiology,The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, 350001, People's Republic of China.

ORCID-Profile: Bo Long

Zitieren

APA

Yang, L., Huang, Y., & Long, B. (2026). Pharmacological Inhibition of Tropomyosin Receptor Kinase B Reverses Remifentanil-Induced Postoperative Hyperalgesia and Synaptic Remodeling. Journal of Pain Research, Volume 19, 1-11. https://doi.org/10.2147/jpr.s598801

Vancouver

Yang L, Huang Y, Long B. Pharmacological Inhibition of Tropomyosin Receptor Kinase B Reverses Remifentanil-Induced Postoperative Hyperalgesia and Synaptic Remodeling. Journal of Pain Research. 2026;Volume 19:1-11. doi:10.2147/jpr.s598801

BibTeX
@article{Yang2026,
  author = {Yang, Lijun and Huang, Yu and Long, Bo},
  title = {Pharmacological Inhibition of Tropomyosin Receptor Kinase B Reverses Remifentanil-Induced Postoperative Hyperalgesia and Synaptic Remodeling},
  journal = {Journal of Pain Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--11},
  doi = {10.2147/jpr.s598801}
}
Kostenlos starten →